12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Wednesday's after-market session. Inventiva, Bluejay Diagnostics, Xilio Therapeutics, Marinus Pharma, Dare Bioscience, and Alzamend Neuro saw increases, while Great Elm Group, 4D Molecular Therapeutics, Perspective Therapeutics, Avinger, Soligenix, and Oragenics experienced decreases. Great Elm Group's Q4 earnings were released on the same day.
September 20, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alzamend Neuro's shares increased by 7.26% to $0.25.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Bluejay Diagnostics' shares increased by 8.84% to $5.17.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Dare Bioscience's stock moved upwards by 7.49% to $0.49.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Inventiva's stock increased by 11.2% to $4.19.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Marinus Pharma's shares increased by 7.71% to $7.75.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Xilio Therapeutics' shares rose 8.4% to $2.45.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Avinger's shares decreased by 6.46% to $12.9.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Perspective Therapeutics' stock fell 6.6% to $0.28.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
4D Molecular Therapeutics' stock fell 6.9% to $13.5.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Great Elm Group's stock decreased by 14.7% to $1.86. The company's Q4 earnings were released on the same day.
The stock price decreased significantly, possibly due to the company's Q4 earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Oragenics' stock decreased by 6.01% to $2.82.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Soligenix's shares decreased by 6.27% to $0.48.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100